Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-17

Clinical Trial Update: Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating nesiritide (BNP) for improving heart, kidney, and hormonal function in people with reduced heart pumping function. The Mayo Cl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure, Asymptomatic Systolic Dysfunction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-17